Arrowhead Pharmaceuticals

Biotech · Private

RNAi and TRiM (Targeted RNAi Molecule) platforms for therapeutic development

arrowheadpharma.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
40
13 granted · 27 pending
Sector median: 2

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
3067Synthis Therapeutics, Inc.——
3068Ottimo Pharma——
3069Vidasym, Inc——
3070Arrowhead Pharmaceuticals——
3071XTEM PHARMACEUTICALS, INC.——
3072SENEB BIOSCIENCES, INC.——
3073Roivant Sciences——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 13 granted of 40
  • RNAi Agents for Inhibiting Expression of Superoxide Dismutase 1 (SOD1), Compositions Thereof, and Methods of Useapplication
  • RNAi Agents And Compositions for Inhibiting Expression of Angiopoietin-Like 3 (ANGPTL3), And Methods Of Usegranted
  • RNAi Agents for Inhibiting Expression of Microtubule Associated Protein Tau (MAPT), Compositions Thereof, and Methods of Useapplication
  • 5'-CYCLO-PHOSPHONATE Modified Nucleotidesapplication
  • Targeting Lignumsapplication
  • RNAi Agents for Inhibiting Expression of Inhibin Subunit Beta E (INHBE), Pharmaceutical Compositions Thereof, and Methods of Useapplication
  • RNAi Agents for Inhibiting Expression of Receptor for Advanced Glycation End-products, Compositions Thereof, and Methods of Useapplication
  • Anti-transferrin Receptor Antibodies, Conjugates Thereof, And Uses Thereofapplication
  • Integrin Targeting Ligands And Uses Thereofgranted
  • Metabolically Stabilized Carbohydrate Targeting Ligands For Oligonucleotide Conjugatesapplication
  • Hepatic Delivery Platforms For Multimeric RNAi Agent Conjugates and Methods of Use Thereofapplication
  • RNAi Agents for Inhibiting Expression of Beta-ENaC, Compositions Thereof, and Methods of Usegranted

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.